


Photocure stock reacted with a heavy (overdone?) correction after the Q3 report, but has recovered nicely in later weeks. As mentioned in an earlier TradingView analysis ( ), NOK 36 and downwards presented a very good buying opportunity, which culminated when the correction bottomed at NOK 32,5 which was a very solid resistance upwards for a long time. Entry at...
With the #ASH18 conference getting closer, Nordic Nanovector has punched through the 2 year long downtrend from the ATH in December 2016. -------------------------------------------- CEO Eduardo Bravo presented at Jefferies 2018 Global Healthcare Conference 14-15 November 2018 nanoinvestors.wordpress.com Betalutin, the lead product from Nordic Nanovector has...
Nordic Nanovector $NANO.OL pushing above NOK68 resistance on significant volume, closing at strong 70.3 before weekend. This indicates another attempt at breaking out of long time downtrend that has been effect since ATH back in december 2016. Investors are seemingly very satisified with recent Q3 report and #ASH18 abstracts presented by CEO Eduardo Bravo and his...
$NANO.OL now testing relevant technical resistance near NOK 60
Technicals: Nordic Nanovector retraced from recent high to fill gaps down to support at NOK 48, which triggered a strong reversal pattern. Investors will be keen to follow if the stock establishes a trading range above 53 NOK which would represent a breakout from the recent downtrend, and even more if the stock could possibly break free from the almost two year...
Omeros has been consolidating after breaking out of its long downtrend, but looks set to make a new attempt to move upwards, coinciding with a strong move in the $BB etf. Needs volume of trade to confirm this move, while investors are waiting for a list of catalysts to trigger interest.
Omeros has been through a rough patch with shortsellers in full control, coming down from a swinging high last year. With recent good news on several fronts, $OMER is trading well above longtrend, and looking to fully confirm breakout.
Top 50 shareholders list has only shown fairly minor changes during recent share price turmoil, but huge retail following were delighted to see Nordic Nanovector finally land approval to go ahead with PARADIGME pivotal clinical study. NANO spikes back 23.99%. One interesting factor is the substantial gap between 63 and 68 NOK, with more positive news coming the...
Norwegian smallcap biotech Nordic Nanovector recently had a major capitulation event after touch the bottom of yearlong downtrend fueled by weak biotech sentiment on Oslo stock exchange as well as a pronounced distrust to CEO in the norwegian investor community. After former CEO Lugi Costa resigned sentiment has changed drastically, and the stock looks poised to...
After a stellar 2016 (nanoinvestors.wordpress.com), things have been going downhill for the Nordic Nanovector stock. After recently giving a sell signal by crashing through a triple bottom at NOK 68, investors are now looking to the NOK 40 line to see if it can provide support for a bounce.